myocarditis

池田信夫 Retweeted

日本で超過死亡が増えてる件、去年のキャリーオーバーもあるから断定できないけど、米国のFDA諮問機関の３回目接種に関する公開討論でも、ワクチンと超過死亡の相関関係については懸念が指摘されてるんだよね。ワクチンと超過死亡への懸念は、必ずしも荒唐無稽とは言えない。https://t.co/fbj1cL2TQz

— 説教おじさん (@partyhike) September 22, 2021

myocarditis  心筋炎

 

FDA advisory group rejects Covid boosters for most, limits to high-risk groups The vote in favor of boosters came after the committee overwhelmingly rejected recommending the extra shots for the general population.

A Food and Drug Administration advisory panel overwhelmingly voted Friday against giving Pfizer-BioNTech's Covid-19 booster shots to most people on Friday, agreeing only to distribute them to people ages 65 and up as well as those at high risk of severe illness.

“We’re being asked to approve this as a three-dose vaccine for people 16 years of age and older, without any clear evidence if the third dose for a younger person when compared to an elderly person is of value,” said committee member Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

Such feedback led to further debate among the committee members about specific age groups or populations that may be most appropriate for a third dose of vaccine. The panel subsequently narrowed the recommendation to those over age 65 and anyone at higher risk for severe illness.

People at high-risk of exposure at work, such as health care workers and teachers, will likely also be eligible for a booster dose.

US Health Officials Endorse FDA Expert Panel’s Decision On COVID-19 Booster Shot: Dr Fauci Disagrees

Written by Jahnavi Sarma | Updated : September 22, 2021 11:30 AM IST

An expert advisory panel of the FDA had recently said that COVID-19 booster shots should be limited to people above 65 years and those who are at high risk. It has rejected the broader use of the third dose among people aged 16 and above. This means that younger adults may not get the booster dose of the vaccine.

While the debate goes on in the US, many other countries have already started administering the third dose of the COVID-19 vaccine. Despite many experts, and even the World Health Organisation, saying that it may not really be needed, countries including Israel, the UAE, Russia, France, Germany and Italy have already rolled out the booster dose. A recent review in The Lancet also argued that vaccine efficacy against severe Covid is so high, even for the Delta variant, that booster doses are not appropriate for everyone at this stage in the pandemic. Even AstraZeneca endorses this view.

 Boys more at risk from Pfizer jab side-effect than Covid, suggests study

US researchers say teenagers are more likely to get vaccine-related myocarditis than end up in hospital with Covid

Fri 10 Sep 2021 18.00 BST

Healthy boys may be more likely to be admitted to hospital with a rare side-effect of the Pfizer/BioNTech Covid vaccine that causes inflammation of the heart than with Covid itself, US researchers claim.

KNOW THE SIGNS What is myocarditis and are symptoms a risk for children after Covid-19 vaccine?

Terri-Ann Williams, Digital Health Reporter

10:38, 15 Sep 2021

The study looked specifically at the Pfizer/BioNTech vaccine and found that over a four month period, boys aged 12 to 15 with no underlying health issues were four to six-times more likely to be diagnosed with vaccine related myocarditis than ending up in hospital with the bug.

超過死亡の話はよくわからんが、少年のワクチン接種と心筋炎の話は出ているね。